Trial Profile
A Randomized Phase III Trial of Radiation Therapy and Cisplatin Alone or in Combination With Intravenous Triapine in Women With Newly Diagnosed Bulky Stage IB2, Stage II, IIIB, or IVA Cancer of the Uterine Cervix or Stage II-IVA Vaginal Cancer
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 12 Jan 2024
Price :
$35
*
At a glance
- Drugs OCX 191 (Primary) ; Cisplatin
- Indications Adenocarcinoma; Adenosquamous carcinoma; Cervical cancer; Squamous cell cancer; Vulvovaginal cancer
- Focus Therapeutic Use
- 23 Sep 2023 Planned End Date changed from 21 Jun 2024 to 21 Sep 2024.
- 23 Sep 2023 Planned End Date changed from 21 Jun 2024 to 21 Sep 2024.
- 23 Jun 2023 Planned End Date changed from 23 Jul 2023 to 21 Jun 2024.